Genomic-scale prioritization of drug targets: the TDR Targets database

Fernán Agüero(National University of General San Martín), Bissan Al‐Lazikani(Biocompatibles (United Kingdom)), Martin Aslett(Wellcome Sanger Institute), Matthew Berriman(Wellcome Sanger Institute), Frederick S. Buckner(University of Washington), R. Keith Campbell(Marine Biological Laboratory), Santiago J. Carmona(National University of General San Martín), Ian M. Carruthers(Biocompatibles (United Kingdom)), A. W. Edith Chan(Biocompatibles (United Kingdom)), Feng Chen(University of Pennsylvania), Gregory J. Crowther(University of Washington), Maria Doyle(University of Melbourne), Christiane Hertz‐Fowler(Wellcome Sanger Institute), Andrew L. Hopkins(University of Dundee), Gregg McAllister(Brandeis University), Solomon Nwaka(Special Programme for Research and Training in Tropical Diseases), John P. Overington(Biocompatibles (United Kingdom)), Arnab Pain(Wellcome Sanger Institute), Gaia V. Paolini(Pfizer (United Kingdom)), Ursula Pieper(University of California, San Francisco), Stuart A. Ralph(University of Melbourne), Aaron Riechers(University of Washington), David S. Roos(University of Pennsylvania), Andrej Săli(University of California, San Francisco), Dhanasekaran Shanmugam(University of Pennsylvania), Takashi Suzuki(Wellcome Sanger Institute), Wesley C. Van Voorhis(University of Washington), Christophe L. M. J. Verlinde(University of Washington)
Nature Reviews Drug Discovery
October 17, 2008
Cited by 310Open Access
Full Text

Abstract


Related Papers